| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 01/25/2007 | WO2007009741A1 Piperazinone derivatives useful as histamine h3 receptor antagonists and/or inverse agonists |
| 01/25/2007 | WO2007009662A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 01/25/2007 | WO2007009250A1 Renin inhibitors |
| 01/25/2007 | WO2007009236A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/25/2007 | WO2007009227A1 Hepatitis c inhibitor peptide analogs |
| 01/25/2007 | WO2006126074A3 Heterocyclic derivatives |
| 01/25/2007 | WO2006065277A3 Heterocyclic aspartyl protease inhibitors |
| 01/25/2007 | WO2006039212A3 Substituted 2h-1,3-benzoxazin-4(3h)-ones |
| 01/25/2007 | WO2006033005A3 Thrombopoietin receptor agonists |
| 01/25/2007 | US20070021609 4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics |
| 01/25/2007 | US20070021607 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 01/25/2007 | US20070021606 Therapeutic compounds |
| 01/25/2007 | US20070021509 Phosphate transport inhibitors |
| 01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/25/2007 | US20070021489 such as (4-{2-[5-Carbamimidoyl-1-oxo-1,3-dihydro-isoindol-2-yl]-acetyl}-phenoxy)-acetic acid methyl ester, used for inhibiting the binding of fibrinogen to blood platelets, platelet aggregation and for the treatment of thrombotic diseases |
| 01/25/2007 | US20070021486 E.g., N-[[5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl]methyl]butane-1-sulfonamide and 3-chloro-N-[[5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl]methyl]benzenesulfonamide; cannabinoid receptor antagonists |
| 01/25/2007 | US20070021465 antiinflamatory agents such as 3-pyridin-3-yl-5-pyridin-4-yl-4,5-dihydro-1,2-oxazole, that inhibit production and release of certain proinflammatory cytokines such as tumor necrosis factor and high mobility group-1 (HMGB1), a protein that accumulates in serum and mediates delayed lethality |
| 01/25/2007 | US20070021459 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethylsulphanyl)-N-quinolin-3-ylbenzamide; 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethoxy)-N-naphthalin-2-ylbenzamide; obesity, including obesity of the non-insuline-dependent diabetes patients, sleeping disorders, stroke, nausea and vomiting |
| 01/25/2007 | US20070021456 Aminobenzimidazole derivatives |
| 01/25/2007 | US20070021447 2-Imino-4-(thio)oxo-5-poly cyclovinylazolines for use as p13 kinase ihibitors |
| 01/25/2007 | US20070021440 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 01/25/2007 | US20070021426 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/25/2007 | US20070021420 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 01/25/2007 | US20070021419 2-Aminophenyl-4-phenylpyrimidines as kinase inhibitors |
| 01/25/2007 | US20070021417 Catalytic hydrogenation of R N-(4-morpholinyl-3-fluorophenyl)-2-oxo-5-oxazolidinyl-methyl azide to form the methylamine using a aromatic hydrocarbon or aromatic chlorohydrocarbon solvent; fewer by-products; may be acetylated to prepare linezolid without complicated purification steps |
| 01/25/2007 | US20070021414 1-'2-(4-Hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists |
| 01/25/2007 | US20070021410 Such as N-[1-(2-amino-3-methylbutyl)-4-piperidinyl]-3-[(2-methoxyethoxy)(6-methyl-2-pyridinyl)methyl]-7-methyl-3H-imidazo[4,5-b]pyridin-2-amine; infant infections |
| 01/25/2007 | US20070021407 Substituted quinolines as antitumor agents |
| 01/25/2007 | US20070021406 New neurokinin antagonists for use as medicaments |
| 01/25/2007 | US20070021405 Aryl- and heteroarylpiperidinecarboxylate-derivatives methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/25/2007 | US20070021403 Piperidinylalkylcarbamate derivatives, methods for their preparation and the therapeutic use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/25/2007 | US20070021390 thiazole, oxazole derivatives useful for treating neurodegenerative disorders or pain |
| 01/25/2007 | US20070021386 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 01/25/2007 | US20070021354 Viricides; immunomoderator; mixture with other Aids drugs |
| 01/25/2007 | US20070020672 Nucleic acid melting analysis with saturation dyes |
| 01/25/2007 | CA2616063A1 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives as v1a receptor antagonists |
| 01/25/2007 | CA2615813A1 Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists |
| 01/25/2007 | CA2615751A1 N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof |
| 01/25/2007 | CA2615596A1 Ethanolamine salt of n- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-oxadiazole-2-yl] phenyl) pyridine-3- sulphonamide |
| 01/25/2007 | CA2615380A1 Quinazoline derivatives useful in cancer treatment |
| 01/25/2007 | CA2615373A1 Quinazoline derivatives useful in cancer treatment |
| 01/25/2007 | CA2615236A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 01/25/2007 | CA2615048A1 Renin inhibitors |
| 01/25/2007 | CA2615045A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/24/2007 | EP1746095A1 Indanol derivative |
| 01/24/2007 | EP1746094A1 Compound having oxadiazole ring structure substituted with pyridyl group, and organic electroluminescent device |
| 01/24/2007 | EP1745784A1 Oxazolidinone derivatives and use thereof as antibiotics |
| 01/24/2007 | EP1745289A2 Methods and antibodies for nitrofuran detection |
| 01/24/2007 | EP1745041A2 Quinoxaline inhibitors of the hedgehog signalling pathway |
| 01/24/2007 | EP1745040A1 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors |
| 01/24/2007 | EP1745038A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
| 01/24/2007 | EP1745034A1 Vanilloid receptor ligands and their use in treatments |
| 01/24/2007 | EP1745029A1 Substituted morpholine compounds for the treatment of central nervous system disorders |
| 01/24/2007 | EP1745027A1 Compounds and compositions as ppar modulators |
| 01/24/2007 | EP1745024A1 1-aryl-4-substituted isoquinolines |
| 01/24/2007 | EP1745019A1 Novel compounds of proline and morpholine derivatives |
| 01/24/2007 | EP1745018A1 Azetidine glycine transporter inhibitors |
| 01/24/2007 | EP1744754A1 Morpholine compounds |
| 01/24/2007 | EP1377555B1 A dioxino[2,3-g]quinoline-9-carboxylic acid derivative as nk3 receptor antagonist |
| 01/24/2007 | EP0968206B8 N-heterocyclic derivatives as nos inhibitors |
| 01/24/2007 | CN1902193A Quinoxalines useful as inhibitors of protein kinases |
| 01/24/2007 | CN1902181A Benzimidazoles useful as modulators of ion channels |
| 01/24/2007 | CN1902168A Novel1,3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands |
| 01/24/2007 | CN1901971A Cyclopropane compounds and pharmaceutical use thereof |
| 01/24/2007 | CN1901917A (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 01/24/2007 | CN1901916A Quinazolinone compounds with reduced bioaccumulation |
| 01/24/2007 | CN1901908A Therapeutic compounds and uses thereof |
| 01/24/2007 | CN1900074A Substituted oxazolidinones and their use in the field of blood coagulation |
| 01/24/2007 | CN1900069A 2-substituted sulfonyl-5-(3,4,5-tri alkoxylphenyl) 1,3,4-oxdiazole derivatives and preparing method and use |
| 01/23/2007 | US7166722 The monohydrochloric acid salt monohydrate, and its preparation by adding hydrochloric acid to a solution of N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea in an N,N-dimethylformamide or N,N-dimethylacetamide aprotic solvent, adding ethanol and ethanol and water |
| 01/23/2007 | US7166715 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds |
| 01/23/2007 | US7166636 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
| 01/23/2007 | US7166629 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 01/23/2007 | US7166624 Antibiotics; e.g N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-trifluoromethyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide; N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-methyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide |
| 01/23/2007 | US7166618 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 01/23/2007 | US7166617 Cyclic amide derivatives |
| 01/23/2007 | US7166616 Substituted alkanoic acids |
| 01/23/2007 | US7166615 Substituted indolinones, preparation thereof and their use as pharmaceutical compositions |
| 01/23/2007 | US7166609 Osteoarthritis; periodontal disease; antiarthritic agents |
| 01/23/2007 | US7166608 for use with various disorders including sleep disorders; depression; cardiovascular disorders; pain; neurodegenerative disorders; psychiatric disorders etc. |
| 01/23/2007 | US7166607 Substituted indoles |
| 01/23/2007 | US7166604 N-Heterocyclic derivatives; picornavirus infections in mammals; human rhinovirus |
| 01/23/2007 | US7166598 Piperazine derivatives |
| 01/23/2007 | US7166593 Glucocorticoid receptor modulators |
| 01/23/2007 | US7166592 Antiinflammatory agents |
| 01/23/2007 | US7166588 Derivatives and analogs of galanthamine |
| 01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
| 01/23/2007 | CA2206754C Benzimidazole derivatives with antihistaminic activity |
| 01/18/2007 | WO2007008895A1 Kinase inhibitors |
| 01/18/2007 | WO2007008501A1 Antidiabetic oxazolidinediones and thiazolidinediones |
| 01/18/2007 | WO2007008143A1 Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 01/18/2007 | WO2007008140A1 New pyridine analogues |
| 01/18/2007 | WO2007007910A1 Heterocycle-substituted benzimidazole derivative |
| 01/18/2007 | WO2007007778A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 01/18/2007 | WO2007007688A1 3,5-diamino-1,2,4-triazole derivative |
| 01/18/2007 | WO2007007588A1 Compound having cyclic group with planarity as core |
| 01/18/2007 | WO2007007054A1 Phthalamides, succinimides and related compounds and their use as pharmaceuticals |
| 01/18/2007 | WO2007007041A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 01/18/2007 | WO2007006547A1 Amide derivatives as kinase inhibitors |
| 01/18/2007 | WO2007006534A2 Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity |